Related Experiment Video
Updated: Jun 2, 2026

A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning
Published on: June 22, 2015
Reining in the pharmacological enhancement train: we should remain vigilant about regulatory standards for
1Indiana University Center for Bioethics, IN, USA.
Abstract:
This article challenges recent assumptions that physicians may ethically and legally prescribe psychopharmacological enhancement drugs to patients and the counterintuitive notion that in some cases ingesting an enhancement drug constitutes the more ethical choice than foregoing this option. Enhancement proponents have touted modafinil as an ideal mechanism to improve concentration, alertness, and forego sleep and keep pace with our society's demands. However, patients who use modafinil for these reasons risk potentially severe side effects and addiction, and face unintended consequences related to their cognitive, emotive, and physiological functioning. Importantly, prescribing a controlled substance such as modafinil for performance enhancement and sleep avoidance runs contrary to a physician's ethical duty to the patient and the standard of practice set forth in legal requirements governing the prescription of controlled substances.
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Regulation
Drug Therapy
Antianxiety Medications
Drug Classes and Categories
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

